Next Weeks Broker Price Targets For K2M Group Holdings, Inc. (NASDAQ:KTWO)

Andrew Cummings
October 12, 2017

(NASDAQ:KTWO) in a research report report published on Tuesday. UBS's target suggests a potential upside of 29.94 % from the company's current price.

Several other equities analysts also recently issued reports on KTWO. K2M Group Holdings had 26 analyst reports since August 5, 2015 according to SRatingsIntel. The firm earned "Buy" rating on Wednesday, November 4 by Needham. The stock has "Buy" rating by Oppenheimer on Thursday, June 22. (KTWO) maintained activity of 0.41 million shares that trade hands on average basis while its relative volume is 12.52. Given that its average daily volume over the 30 days has been 406.21K shares a day, this signifies a pretty significant change over the norm. The company has a market cap of $781.52 Million. (KTWO). Moving averages have the ability to be used as a powerful indicator for technical stock analysis. The company rocked its 52-Week High of $25.99 and touched its 52-Week Low of $16.32. (NASDAQ:KTWO) has shown an EPS growth of - in the last 5 years and sales growth of 14.90% for the same year while for the next 5 years; the EPS growth estimates 20.00%.Along with this Sales growth yoy (quarter over quarter) was considered as 11.00%. After $0.34 actual earnings per share reported by Brandywine Realty Trust for the previous quarter, Wall Street now forecasts 2.94% EPS growth. The Return on Equity (ROE) and Return on Investment (ROI) values are -15.4 percent and -10.4 percent respectively. The company had revenue of $65.70 million for the quarter, compared to analyst estimates of $66.26 million. Cytori Therapeutics, Inc. earnings have risen with an annualized rate of 32.5% over the last 5 years. The legal version of this piece can be read at https://weekherald.com/2017/10/11/k2m-group-holdings-inc-ktwo-given-outperform-rating-at-cowen-and-company.html.


04/24/2017 - K2M Group Holdings, Inc. had its "overweight" rating reiterated by analysts at Barclays. The stock has "Buy" rating by Needham on Wednesday, November 4. If you are reading this story on another website, it was illegally copied and reposted in violation of U.S. and global copyright and trademark laws.

06/02/2014 - William Blair began new coverage on K2M Group Holdings, Inc. giving the company a "outperform" rating. The shares were sold at an average price of $23.37, for a total transaction of $919,773.09. NINK's SI was 1,100 shares in October as released by FINRA. The shares were purchased at an average price of $23.30. Following the completion of the transaction, the insider now owns 200,629 shares in the company, valued at approximately $4,674,655.70. The disclosure for this sale can be found here. The company has Beta Value of 1.44 and ATR value of 1.13. TimesSquare Capital Management LLC raised its holdings in K2M Group Holdings by 31.5% during the second quarter. The percentage of shares being held by the company management was 1.8% while institutional stake was 0%. TimesSquare Capital Management LLC increased its position in shares of K2M Group Holdings by 31.5% during the second quarter. A stock that maintains a relatively stable price has low volatility. Vanguard Group Inc. increased its holdings in K2M Group Holdings by 12.4% in the second quarter. Its up 37.5% from 800 shares previously. Finally, Sectoral Asset Management Inc increased its holdings in K2M Group Holdings by 22.9% in the second quarter. American International Group Inc. grew its stake in shares of K2M Group Holdings by 7.1% during the 1st quarter.


K2M Group Holdings, Inc.is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques.


Other reports by iNewsToday

FOLLOW OUR NEWSPAPER